Impact of guidelines on vancomycin use at a Hong Kong teaching hospital [1]

American Journal of Health-System Pharmacy

Volumn 60, Issue 9, 2003, Pages 949-950

  Lee, Vivian W Y ^a   Lyon, Donald J ^b   Fung, Kitty S C ^b   Leung, Teresa P Y ^c   Ng, Joyce K Y ^c   You, Joyce H S ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLITIS; CONTROLLED STUDY; DRUG COST; ENTEROCOCCUS; FEMALE; HEALTH CARE POLICY; HONG KONG; HUMAN; KIDNEY FUNCTION; LETTER; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEPHROTOXICITY; OLIGURIA; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; STAPHYLOCOCCUS AUREUS; TEACHING HOSPITAL;

EID: 0037971026     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.9.949     Document Type: Letter

References (1)

1. You JH, Lyon DJ, Lee BS et al. Vancomycin utilization at a teaching hospital in Hong Kong. Am J Health-Syst Pharm. 2001; 58: 2167-9.